These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1586974)

  • 1. [Preparation of a prekallikrein concentrate and determination of its activator in blood derivatives].
    Simonianová E
    Cesk Farm; 1992 Feb; 41(1):8-9. PubMed ID: 1586974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of prekallikrein in the plasma of neonates].
    Simonianová E; Tomásová H; Rybák M; Zoban P; Mydililová A
    Cesk Pediatr; 1990 Oct; 45(10):596-9. PubMed ID: 2092896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional determination of C1-inhibitors in human blood].
    Simonianová E
    Cas Lek Cesk; 1992 Aug; 131(16):505-7. PubMed ID: 1423463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assay of prekallikrein activator in human blood products.
    Snape TJ; Griffith D; Vallet L; Wesley ED
    Dev Biol Stand; 1979; 44():115-20. PubMed ID: 317467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-step preparation of Hageman factor fragment concentrate.
    Simonianová E
    Biomed Chromatogr; 1992; 6(4):194-5. PubMed ID: 1643388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
    Kaplan AP
    Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
    Espana F; Aznar J; Estelles A
    J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of a chromatographic method for determining kallikrein and prekallikrein in dog blood serum].
    Dotsenko VL; Saiapin VN; Neshkova EA; Iarovaia GA
    Biull Eksp Biol Med; 1982 Aug; 94(8):117-20. PubMed ID: 6922725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a microassay for human plasma prekallikrein.
    De La Cadena RA; Scott CF; Colman RW
    J Lab Clin Med; 1987 May; 109(5):601-7. PubMed ID: 3646287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ; Dooijewaard G; Turion PN
    Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymes of the contact phase of blood coagulation: kinetics with various chromogenic substrates and a two-substrate assay for the joint estimation of plasma prekallikrein and factor XI.
    Retzios AD; Rosenfeld R; Schiffman S
    J Lab Clin Med; 1988 Nov; 112(5):560-6. PubMed ID: 3263454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM; Tankersley DL; Mason BL
    J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of a tripeptide chromogenic substrate for simultaneous determination of 4 indices of kallikrein-kinin system].
    Dotsenko VL; Iarovaia GA; Neshkova EA
    Vopr Med Khim; 1989; 35(2):128-33. PubMed ID: 2741408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextran sulphate inhibits phospholipid and sulphatide mediated autoactivation of factor XII.
    Schousboe I; Rasmussen MS; Lintner R
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):503-9. PubMed ID: 7841305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of IgG from normal plasma and plasma from untreated patients with active Crohn's disease--effect on levels of contact factors.
    Briseid K; Lygren I; Johannesen S; Marthinsen K
    Scand J Clin Lab Invest; 2000 May; 60(3):237-45. PubMed ID: 10885496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay of factor XII in human plasma using prekallikrein or the chromogenic peptide S-2222 as substrates--significance of the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1989 May; 54(3):197-205. PubMed ID: 2787541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein modification with affinity to IgG present in higher amounts than normal in plasma from patients with Crohn's disease.
    Briseid K; Johannesen S
    Scand J Clin Lab Invest; 2003; 63(6):425-9. PubMed ID: 14594323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials.
    van der Kamp KW; van Oeveren W
    J Biomed Mater Res; 1994 Mar; 28(3):349-52. PubMed ID: 7521336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.